Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04860856 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial
A Phase 4 study of Femur Fracture, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT04860856 is a Phase 4 study of Femur Fracture that has completed, run by University of Cincinnati. The registered enrollment target is 88 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04860856, a Phase 4 study of Femur Fracture, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy of an intra-operative, post-fixation fracture hematoma block compared to saline control on postoperative pain control in patients with acute femoral shaft fractures. Our primary outcome measure is visual analog scale (VAS) pain scores which are recorded at regular intervals.
Conditions Studied
Interventions
- DRUG Normal Saline
- DRUG 0.5% ropivacaine
Study Locations (1)
Ohio
- University of Cincinnati College of Medicine - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2019-08-17 |
| Est. Completion | 2023-02-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04860856
The ClinicalTrials.gov registry entry for NCT04860856 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Femur Fracture appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline is the first listed.
NCT04860856 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04860856 about?
NCT04860856 is a clinical study titled "Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial". The purpose of this study is to evaluate the efficacy of an intra-operative, post-fixation fracture hematoma block compared to saline control on postoperative pain control in patients with acute femoral shaft fractures. Our primary outcome measure is visual analog scale (VAS) pain scores which are r...
What is the current status of trial NCT04860856?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2019-08-17. Estimated completion is 2023-02-07.
What conditions does trial NCT04860856 study?
This clinical trial studies the following conditions: Femur Fracture.
What interventions are being tested in trial NCT04860856?
The interventions under investigation include: Normal Saline (DRUG), 0.5% ropivacaine (DRUG).
Who is sponsoring clinical trial NCT04860856?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04860856 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femur Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.